University Hospital, Bonn
ukbonn.deTotal trials
152
Active
26
Phase 3
13
Total enrollment
29,030
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Immunotherapy | — | — | — | — | — | 1 |
Next readouts
- 2029-12-31
Top conditions
- Healthy7
- Depression6
- Portal Hypertension5
- Heart Diseases4
- Cardiomyopathies4
- Depressive Disorder3
- Healthy Male Volunteers3
- Pseudoxanthoma Elasticum3
Frequently asked questions about University Hospital, Bonn
- How many clinical trials does University Hospital, Bonn have on ClinicalTrials.gov?
- University Hospital, Bonn is listed as the lead sponsor on 152 clinical trials in ClinicalTrials.gov, 26 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital, Bonn's trials are in Phase 3?
- 13 of University Hospital, Bonn's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University Hospital, Bonn focus on?
- University Hospital, Bonn's most-studied conditions on ClinicalTrials.gov are Healthy, Depression, Portal Hypertension, Heart Diseases, Cardiomyopathies.
- When are University Hospital, Bonn's next clinical trial readouts?
- University Hospital, Bonn has 1 upcoming primary-completion readout tracked here; the soonest is “Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC”, expected around 2029-12-31.